Drug Shortage Report for CONSTELLA

Last updated on 2023-09-22 History
Report ID 203963
Drug Identification Number 02417170
Brand name CONSTELLA
Common or Proper name Constella 290mg
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) LINACLOTIDE
Strength(s) 290MCG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 30 capsules bottle
ATC code A06AX
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-09-08
Estimated end date 2023-09-29
Actual end date 2023-09-21
Shortage status Resolved
Updated date 2023-09-22
Company comments Constella 72 mcg caps and 145 mcg caps remain available
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-09-22 English Compare
v9 2023-09-21 French Compare
v8 2023-09-21 English Compare
v7 2023-09-14 French Compare
v6 2023-09-14 English Compare
v5 2023-09-14 French Compare
v4 2023-09-14 English Compare
v3 2023-09-14 French Compare
v2 2023-09-14 English Compare
v1 2023-09-08 English Compare

Showing 1 to 10 of 10